BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9632718)

  • 1. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.
    Jean D; Gershenwald JE; Huang S; Luca M; Hudson MJ; Tainsky MA; Bar-Eli M
    J Biol Chem; 1998 Jun; 273(26):16501-8. PubMed ID: 9632718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene regulation in melanoma progression by the AP-2 transcription factor.
    Bar-Eli M
    Pigment Cell Res; 2001 Apr; 14(2):78-85. PubMed ID: 11310795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of AP-2 in tumor growth and metastasis of human melanoma.
    Bar-Eli M
    Cancer Metastasis Rev; 1999; 18(3):377-85. PubMed ID: 10721491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
    Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
    Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.
    Huang S; Jean D; Luca M; Tainsky MA; Bar-Eli M
    EMBO J; 1998 Aug; 17(15):4358-69. PubMed ID: 9687504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the elements regulating the expression of the cell adhesion molecule MCAM/MUC18. Loss of AP-2 is not required for MCAM expression in melanoma cell lines.
    Mintz-Weber CS; Johnson JP
    J Biol Chem; 2000 Nov; 275(44):34672-80. PubMed ID: 10938273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
    Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
    Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.
    Pickl WF; Majdic O; Fischer GF; Petzelbauer P; Faé I; Waclavicek M; Stöckl J; Scheinecker C; Vidicki T; Aschauer H; Johnson JP; Knapp W
    J Immunol; 1997 Mar; 158(5):2107-15. PubMed ID: 9036955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma progression-associated glycoprotein MUC18/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand.
    Johnson JP; Bar-Eli M; Jansen B; Markhof E
    Int J Cancer; 1997 Nov; 73(5):769-74. PubMed ID: 9398060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
    Xie S; Price JE; Luca M; Jean D; Ronai Z; Bar-Eli M
    Oncogene; 1997 Oct; 15(17):2069-75. PubMed ID: 9366524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of melanoma metastasis.
    Bar-Eli M
    J Cell Physiol; 1997 Nov; 173(2):275-8. PubMed ID: 9365536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice.
    Schlagbauer-Wadl H; Jansen B; Müller M; Polterauer P; Wolff K; Eichler HG; Pehamberger H; Konak E; Johnson JP
    Int J Cancer; 1999 Jun; 81(6):951-5. PubMed ID: 10362144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of metastasis-related genes in human melanoma.
    Nyormoi O; Bar-Eli M
    Clin Exp Metastasis; 2003; 20(3):251-63. PubMed ID: 12741683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular changes in human melanoma metastasis.
    Luca MR; Bar-Eli M
    Histol Histopathol; 1998 Oct; 13(4):1225-31. PubMed ID: 9810513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma.
    Melnikova VO; Dobroff AS; Zigler M; Villares GJ; Braeuer RR; Wang H; Huang L; Bar-Eli M
    PLoS One; 2010 Aug; 5(8):e12452. PubMed ID: 20805990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectopic expression of MCAM/MUC18 increases in vitro motility and invasiveness, but decreases in vivo tumorigenesis and metastasis of a mouse melanoma K1735-9 subline in a syngeneic mouse model.
    Wu GJ
    Clin Exp Metastasis; 2016 Dec; 33(8):817-828. PubMed ID: 27510563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression.
    Zigler M; Villares GJ; Dobroff AS; Wang H; Huang L; Braeuer RR; Kamiya T; Melnikova VO; Song R; Friedman R; Alani RM; Bar-Eli M
    Cancer Res; 2011 May; 71(10):3494-504. PubMed ID: 21467165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct correlation between MUC18 expression and metastatic potential of human melanoma cells.
    Luca M; Hunt B; Bucana CD; Johnson JP; Fidler IJ; Bar-Eli M
    Melanoma Res; 1993 Feb; 3(1):35-41. PubMed ID: 8471835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Hsp27 in a human melanoma cell line: regulation of E-cadherin, MUC18/MCAM, and plasminogen activator (PA) system.
    Aldrian S; Kindas-Mügge I; Trautinger F; Fröhlich I; Gsur A; Herbacek I; Berger W; Micksche M
    Cell Stress Chaperones; 2003; 8(3):249-57. PubMed ID: 14984058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell adhesion molecules in the development and progression of malignant melanoma.
    Johnson JP
    Cancer Metastasis Rev; 1999; 18(3):345-57. PubMed ID: 10721489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.